BET protein inhibition shows efficacy against JAK2V617F driven neoplasms.
Wyspianska B, Bannister AJ, Barbieri I, Nangalia J, Godfrey A, Calero-Nieto FJ, Robson S, Rioja I, Li J, Wiese M, et al. BET protein inhibition shows efficacy against JAK2V617F driven neoplasms. Leukemia. 2013.